RecruitingNot ApplicableNCT07139808

Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System

Sponsor

Henan University of Science and Technology

Enrollment

12 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Type1diabetes

Summary

The study is to evaluate the accuracy and safety of a novel real-time continuous glucose and ketone monitoring system among adult patients with type 1 diabetes mellitus (T1DM) with respect to Yellow Spring Instrument (YSI) and Randox reference venous plasma sample measurements.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called GK5 CGKM for people with type1diabetes. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEGK5 CGKM

Wear for a consecutive 15 days

Locations(2)

The First Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Henan University of Science and Technology

Luoyang, Henan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07139808

Related Trials

Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System

NCT070927611 location

Exercise Training and Endothelial Function in Type 1 Diabetes

NCT035282261 location